ArticleInternational journal of surgery (London, England)2026
68 Ga-pentixafor PET/CT versus adrenal venous sampling in guiding surgical management for primary aldosteronism: a prospective cohort study on postoperative outcomes.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- DeltaAnnals of surgical oncology · 2026Article
- Primary Aldosteronism Subtype Diagnosis: Adrenal Venous Sampling vs. CXCR4 PET CT.Endocrinology, diabetes & metabolism · 2026Article
- ⁶⁸GA-Pentixafor PET/CT: a non-invasive molecular alternative to adrenal venous sampling in primary aldosteronism.EJNMMI reports · 2026Review
- Emerging methods for subtype differentiation in primary aldosteronism.Journal of internal medicine · 2026Review
- The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015-2025).Theranostics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimitations still exist in the surgical strategies for primary aldosteronism (PA), the most common cause of secondary hypertension. This study aimed to compare the effectiveness of 68 Ga-pentixafor PET/CT versus adrenal venous sampling (AVS) in guiding surgical management for PA. MATERIALS AND
methodsA prospective cohort of 197 PA patients were assigned to Group PET (n = 137) and Group AVS (n = 60), in which the surgical interventions were guided by 68 Ga-pentixafor PET/CT and AVS, respectively. Postoperative clinical and biochemical outcomes were analyzed referring to Primary Aldosteronism Surgical Outcomes classification system, with subgroup analysis on clinical characteristics and outcomes conducted in Group PET.
resultsDuring a median follow-up of 27 (16, 39) months, the postoperative clinical and biochemical outcomes were comparable between 134 patients in Group PET and 57 patients in Group AVS, with unilateral or bilateral adrenal lesions. The rates of complete, partial, and absent clinical success were 51.5%, 38.1%, 10.4% in Group PET, and 35.1%, 50.9%, 14.0% in Group AVS ( P = 0.115). For biochemical success, the corresponding rates were 82.1%, 12.7%, 5.2% in Group PET, and 75.4%, 17.5%, 7.0% in Group AVS ( P = 0.533). The proportion of complete biochemical success was significantly higher than that of complete clinical success (80.10% vs 46.6%, P < 0.001). Female gender was associated with increased likelihood of complete clinical and biochemical success, and lower preoperative systolic blood pressure and shorter duration of hypertension indicated increased likelihood of complete clinical success. The SUV max was significantly correlated with lesion diameters, age, duration of hypertension, blood potassium level, pathological type and clinical outcomes. A cutoff value of 5.5 for SUV max demonstrated a sensitivity of 82.8% and a specificity of 92.6% in identifying functional adrenal lesions with autonomous aldosterone secretion.
conclusions68 Ga-pentixafor PET/CT demonstrated potential non-inferiority to AVS in guiding the surgical management for PA patients, with comparable postoperative clinical and biochemical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.